Stockreport

Clene Reports Third Quarter 2024 Financial Results and Recent Operating Highlights

Clene Inc.  (CLNN) 
PDF Clene met with the U.S. Food and Drug Administration (FDA) on November 1, 2024, in a Type C meeting to discuss the potential for an accelerated approval pathway in ALS a [Read more]